This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Glenview Calls Community Health's $3.6B Deal for Health Management 'Floor Value'

NEW YORK ( TheStreet) -- Hedge fund Glenview Capital Management is not supporting Community Health Systems (CYH - Get Report) $3.6 billion proposed acquisition of Health Management Associates (HMA) and instead characterizes the deal as a "floor value" for shareholders as it continues to press management change.

Glenview said it will continue to press a slate of board directors to replace H.M.A's existing management instead of supporting the proposed merger announced early Tuesday morning.

"Glenview believes that the Community Proposal establishes an important floor value for HMA shareholders to evaluate," the firm said in a Tuesday statement.

"Given the management turnover and deterioration of performance under the sitting Board we believe it is imperative that shareholders promptly replace the sitting Board with the Fresh Alternative nominees."

The hedge fund says that with the support of adviser Alvarez & Marsal it would effect operational change, better compliance, stronger financial forecasting, and the consideration of additional strategic alternatives to go with Community Health's proposed acquisition.

Glenview's comments indicate the firm believes it can garner takeover interest for H.M.A beyond Community Health, potentially increasing the value of the company to shareholders.

In arguing for support of its board directors, Glenview also pointed to H.M.A's weak earnings performance in recent quarters, the disclosure of a Department of Justice inquiry into its patient admission practices and a lack of experience among top company executives.

Still the firm did call Tuesday's proposed deal an "important step" for H.M.A shareholders.

Earlier on Tuesday, Community Health said it would pay $10.50 a share in cash and 0.06942 of a share for each share of H.M.A, valuing the company at about $13.78 a share, based on Monday's closing stock prices. H.M.A shareholders will also receive a contingent value right worth up to $1 a share if the hospitals network can resolve legal issues tied to its patient admission practices.

H.M.A's proposed sale to Community Health values the firm's shares at $3.6 billion and comes amid a merger wave among hospital and health care giants. Whether shareholders approve the deal, however, remains uncertain.

About 70% of H.M.A's shareholders need to approve Community Health's acquisition for the deal to pass.

In late 2012, Glenview Capital Management became a top H.M.A shareholder and has campaigned for the company to consider strategic alternatives such as a sale. The hedge fund also recently proposed a slate of board directors to replace the company's existing management.

Glenview is giving investors 60 days to submit votes on H.M.A's board directors and disclosed the plan on July 18. Because H.M.A did not put a go-shop period in place, Glenview would likely have to win its board ouster to consider alternatives to Tuesday's Community Health deal.

As part of the merger, H.M.A said it has ended a strategic review it began earlier in 2013. The company also said it has named John M. Starcher interim CEO to replace William J. Schoen.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
HMA $0.00 0.00%
CYH $15.02 1.01%
HCA $79.80 0.94%
ILMN $134.97 0.99%
THC $31.46 -1.53%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs